Overview

Safety and Efficacy of Lansoprazole in Patients With Reflux Disease

Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to measure the safety, efficacy and quality of life of lansoprazole in patients with reflux disease over a five year period.
Phase:
Phase 4
Details
Lead Sponsor:
Takeda
Treatments:
Dexlansoprazole
Lansoprazole